Newswire (Published: Thursday, November 15, 2018, 12:01:00 PM CST, Received: Thursday, November 15, 2018, 12:14:22 PM CST)

Word Count: 515

By a News Reporter-Staff News Editor at Cancer Weekly -- New research on Oncology - Prostate Cancer is the subject of a report. According to news reporting originating in Salt Lake City, Utah, by NewsRx journalists, research stated, "Black men are diagnosed with prostate cancer at nearly twice the rate of white men and are underrepresented in prostate cancer research, including validation studies of new clinical tools (e.g., genomic testing). Because healthcare system mistrust has contributed to these disparities for centuries, black men may be less inclined to pursue novel testing, and identification of facilitators to their participation in prostate cancer research studies remains warranted."

The news reporters obtained a quote from the research from the University of Utah, "A community-engaged approach involving a partnership with a community organization was used to conduct seven focus groups in Minnesota, Alabama, and California to explore black men's attitudes toward prostate cancer research participation and genomic testing for prostate cancer. Data were collected and analyzed from April 2015 to April 2017. Identified genomic testing barriers included a lack of terminology understanding, healthcare system mistrust, reluctance to seek medical care, and unfavorable attitudes toward research. Facilitators included family history, value of prevention, and the desire for health education. Lack of prostate cancer knowledge, prostate-specific antigen testing confusion, healthcare system distrust, and misuse of personal health information were barriers to research study participation. Some black men were motivated to participate in research if it was seen as constructive and transparent. Disparities for black men can both motivate and disincentivize participation depending upon a positive or negative view of research. Confusion over prostate cancer clinical care has fueled some mistrust among black men affecting both clinical care and research participation."

According to the news reporters, the research concluded: "With increased education, health literacy, and assurances of research integrity and transparency, black men may be more willing to participate in prostate cancer testing and research."

For more information on this research see: Attitudes Toward Genomic Testing and Prostate Cancer Research Among Black Men. American Journal of Preventive Medicine, 2018;55(5):S103-S111. American Journal of Preventive Medicine can be contacted at: Elsevier Science Inc, 360 Park Ave South, New York, NY 10010-1710, USA. (Elsevier -; American Journal of Preventive Medicine -

Our news correspondents report that additional information may be obtained by contacting C.R. Rogers, University of Utah, Sch Med, Dept. of Family & Prevent Med, Salt Lake City, UT 84108, United States. Additional authors for this research include M.J. Rovito, M. Hussein, O.J. Obidike, R. Pratt, M. Alexander, J.M. Berge, M. Dall'Era, J.W. Nix and C. Warlick (see also Oncology - Prostate Cancer).

The direct object identifier (DOI) for that additional information is: This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

(Our reports deliver fact-based news of research and discoveries from around the world.)


The University of Utah


North America
United States
New York
New York City
Salt Lake City


Science and Technology
      Scientific Research
Health and Wellness
      Medical Conditions and Diseases
                  Prostate Cancer
            Men's Health Issues
                  Prostate Cancer
      Health Sciences
            Medical Research
      Health Policy and Debates
Life and Society